Title of article
Citicoline in the treatment of acute ischaemic stroke: an international, randomized, multicentre, placebo-controlled study (ICTUS trial)Is the use of Citicoline is beneficial for acute ischaemic stroke?
Author/Authors
Nomani, Fauzia Aga Khan University Hospital - Fogarty International Center and National Institute of Neurologic Disorders and Stroke - Stroke Service and Vascular Fellowship Program, International Cerebrovascular Translational Clinical Research Training Program, Pakistan , Kamal, Ayeesha Kamran Aga Khan University Hospital - Fogarty International Center and National Institute of Neurologic Disorders and Stroke - Stroke Service and Vascular Fellowship Program, International Cerebrovascular Translational Clinical Research Training Program, Pakistan
From page
1445
To page
1445
Abstract
Stroke is the leading cause of disability in the world population Citicoline is an exogenous form of cytidine 5 - diphosphatecholine, an important component of the cellular membrane, is a medication believed to have combined neurovascular protection and repair effects. It is extensively studied in many clinical trials in patients including ischaemic stroke however promising results on meaningful clinical recovery and reduction of disability is lacking.
Journal title
Journal of the Pakistan Medical Association (Centre) JPMA
Journal title
Journal of the Pakistan Medical Association (Centre) JPMA
Record number
2653215
Link To Document